Monthly Archives: January 2019

Eight myths about meal-replacement diets debunked

I have been recommending and using meal replacement diets for the last 30 years- long before they became fashionable. I have found them to be easy to use, safe and effective. The one I find best and recommend is the Medical Vitadiet, available from most chemists. More information is available on http://www.vitadiet.com.au. This article from Oxford University confirms what I have known for many years.

Eight myths about meal-replacement diets debunked

January 29, 2019 11.01pm AEDT Jiri Hera/Shutterstock

Author

  1. Nerys M Astbury Senior Researcher, Diet and Obesity, University of Oxford

Disclosure statement

Nerys M Astbury receives funding from National Institutes of Health Research (NIHR) Collaboration for Leadership in Health Research and Care Oxford and NIHR Biomedical Research Centre Oxford, and has been co-investigator on a research grant from Cambridge Weight Plan UK.

Partners

University of Oxford

University of Oxford provides funding as a member of The Conversation UK.

Meal-replacement diets, where some meals are replaced with soups, shakes or bars, have been making a comeback. They first took off during the early days of space travel when the public became obsessed with the idea of a nutritionally complete meal in a single drink or bar. These products remained popular for most of the 70s and 80s, but gradually fell from favour as people began to question the health benefits of these diets.

There are many myths surrounding meal-replacement diets, so we set out to scrutinise the evidence. Drawing on our own research and that of others, we can now debunk some of these myths.

1. They’re too complicated

Swapping some of your usual meals, which might contain between 500-800 calories, with meal replacement products that typically contain 200-300 calories each, helps reduce your daily calorie intake. It is this calorie control that is the key feature of any successful weight-loss diet. Since the meal replacement products are calorie and portion controlled, it’s a lot easier to follow this type of diet than one where calories have to be calculated.

2. I’ll be limited to repetitious shakes

Meal-replacement products have come a long way from chalky-tasting shakes that only come in one flavour. Today there is a wide range of products to choose from, including the traditional shakes in flavours to suit all tastes (including vanilla chai and mint choc chip), soups, bars, smoothies and even some prepackaged meals, meaning that your diet won’t be dull or boring.

3. They don’t work

Our latest systematic review on the effectiveness of meal replacements for weight loss included 23 clinical trials that compared weight loss in people who followed a meal replacement diet with a weight-loss plan that didn’t include meal replacements. We combined similar trials into groups for analysis. Across each group, although people in the control programmes lost weight, the people who followed a meal replacement diet lost significantly more weight after one year.

On average, people who followed a meal-replacement diet lost 1.4kg more than people using other diets after one year. Those who followed a meal-replacement diet, combined with support from a dietitian or healthcare professional, lost 2.2kg more than those who followed an alternative type of weight-loss diet (with no support), and 3.9kg more than those who followed an alternative type of weight-loss diet combined with support.

4. They’re a quick fix

Although only a few of the studies included in our latest review reported on long-term follow up (which is common for diet and weight loss studies), the studies that did have a longer follow up showed that people who followed a programme that included meal replacements weighed less than when they began the programme up to four years later.

Meal replacement diets can have a lasting effect on weight loss. Rostislav_Sedlacek/Shutterstock

5. They’re unsafe

Some people believe that diets that limit the intake of “real food” can cause headaches, insomnia, fatigue, constipation and diarrhoea. But these are common side effects associated with many forms of dieting and are not limited to the use of meal replacements.

In our latest review, although many studies did not report harms, the studies that did report harms found no evidence that using meal replacements for weight loss caused any more serious side effects than other sorts of weight-loss programmes (including traditional diets using real food).

6. I’ll feel hungry all the time

Meal-replacement products are formulated to be high in protein and fibre, both ingredients that have been shown to suppress appetite. Even though the portions look small, they fill you up so you won’t feel hungry and go seeking calorific snacks between meals.

7. I’ll end up with a poor quality diet

When people reduce the amount of food they eat in order to lose weight, it becomes more difficult to get the recommended intakes of nutrients that are essential for good health. However, our review found that the use of meal replacements in an energy restricted diet was not associated with any nutritional deficiencies. This is presumably because the meal replacements are fortified with vitamins and minerals to meet strict regulations on their composition.

8. I might lose weight but I’ll still be unhealthy

Our review showed that risk factors for disease including HbA1c, a blood marker used to diagnose type 2 diabetes, improved more in people using meal replacement than in those using other types of weight loss programme.

If you’re considering losing weight, our latest evidence suggests that replacement diets can be a sound option.

Confused by Nutrition Research? Sloppy Science May Be to Blame

Personal Health

Confused by Nutrition Research? Sloppy Science May Be to Blame

According to a new book by Marion Nestle, the unstated goal of most company-sponsored studies is to increase the bottom line.

Image
CreditCreditGracia Lam

Confused about what to eat and drink to protect your health? I’m not surprised.

For example, after decades of research-supported dietary advice to reduce saturated fats to minimize the risk of heart disease and stroke, along comes a new observational study of 136,384 people in 21 countries linking consumption of full-fat (read saturated) dairy foods to a lower risk of death from cardiovascular disease.

But without dissecting each study included in this meta-analysis, it is not possible to say what might be behind this surprising result and whether you should now resume putting cream in your coffee and whole milk in your cereal bowl. The study may simply mean that consuming the equivalent of three servings of dairy products a day is healthful, not saturated fat per se.

Caution is in order, especially since another new study, this one a randomly assigned clinical trial, found that three weeks on a diet rich in saturated fat caused liver fat and insulin resistance to rise far higher than diets high in sugar or unsaturated fat.

Or maybe you bought into the hype about pomegranate juice as an antioxidant superfood, only to learn from an illuminating new book that the health-promoting evidence for this expensive fruit drink derives mainly from $20 million of company-sponsored research.

In the book, “Unsavory Truth: How Food Companies Skew the Science of What We Eat,” Marion Nestle, emerita professor of nutrition, food studies and public health at New York University, points out that “pomegranates might have high antioxidant activity,” then asks “compared to what?” Are they more healthful than (much cheaper) grapes?

Here’s how the company POM Wonderful responded to Dr. Nestle’s challenge: “Comparing the health benefits of our product to other juices is not a key objective of our extensive research program.” To which I would ask, “If you’re selling ‘health,’ why wouldn’t it be?”

The answer, as Dr. Nestle’s extensive research shows, is that the unstated goal of most company-sponsored studies is to increase the bottom line. “It’s marketing research, not science,” she said in an interview. It matters not whether the food in question is considered healthy, like wild blueberries and avocados, or it’s laden with health-robbing calories from fats, sugars and refined starches.

Noting that nutrition research, especially that funded by industry, “requires careful interpretation,” she suggests an approach that all consumers would be wise to follow:

“Whenever I see studies claiming benefits for a single food, I want to know three things: whether the results are biologically plausible; whether the study controlled for other dietary, behavioral, or lifestyle factors that could have influenced its result; and who sponsored it.”

Consider the studies sponsored by the soft-drink industry, in which Coca-Cola has led an effort to undermine the contribution of sugar-laden carbonated water to the nation’s obesity epidemic. For example, the company funded a study of childhood obesity that, without looking for a possible link between overweight and sugary soft drinks, concluded that low physical activity, inadequate sleep and lots of television watching were most important.

To make such conclusions appear valid, Coca-Cola enlisted the participation of university-based scientists all of whom stood, directly or indirectly, to profit financially from their association with the research.

The “who sponsored it” issue forms the crux of Dr. Nestle’s book. It is a critically important question to ask, not just with regard to foods, but also for drugs, supplements, exercise regimens, skin creams, mattresses and any other product or service that may — or may not — impact the health of consumers.

Increasingly, actual or potential conflicts of interests — factors that can consciously or subconsciously influence the outcomes of research — are being brought to public attention. In September, the director of clinical research at the prestigious Memorial Sloan Kettering Cancer Center relinquished his post after failing to disclose the millions of dollars he received from pharmaceutical companies whose drugs he studied. An investigation revealed that he had put a positive spin on results that other researchers found wanting.

In September, a piece in the Upshot section of The New York Times described yet another type of conflict prominent in the reporting of drug trials: What studies get published (most negative findings never see the light of day), how their results are reported and spin that casts negative or nonsignificant findings in a positive light. The problem is often confounded hundreds of times when these spurious study results are cited over and over again by other researchers.

“Fifty years of research has demonstrated the influence of pharmaceutical companies on physicians’ behavior — even giving doctors pads or pens printed with the brand name of a drug can prompt doctors to ignore a generic or competing brand,” Dr. Nestle told me.

However, Dr. Nestle said, while there have been thousands of studies of conflicts of interest among physicians who publish drug studies and those who prescribe industry-touted medications, she could identify only 11 such studies of the influence of industry funding on the outcome of food and beverage research in relation to health.

Consumers who are not scientifically savvy can be easily misled by the findings of studies, especially when they emanate from a prestigious institution or professional association. Dr. Nestle says such organizations need to pay closer attention to both blatant and potential conflicts of interest lest they be caught touting sloppy science.

She cited, for example, a 2015 company-funded study at the University of Maryland of Fifth Quarter Fresh, a nonfat chocolate milk laced with vitamins and 42 grams of sugar. Although the study had not been peer-reviewed or published in a professional journal, a university news release claimed the drink could counter the brain effects of concussions in high school football players. Chastised for its ethical failings, the university returned nearly $230,000 to commercial sponsors.

In her book, Dr. Nestle documents how commercial sources have co-opted many of the organizations that members of the public, and even science writers like me, rely on to provide unbiased assessments of research results. Even experts in organizations and on panels that formulate health advice for the public can be tainted by commercial influences, she found.

There is an inherent conflict, for example, within the United States Department of Agriculture, which has two potentially opposing mandates. The agency is supposed to support production of all kinds of agricultural products — meat, poultry and dairy, as well as fruits and vegetables — and it participates with the Department of Health and Human Services in formulating national dietary guidelines and nutrient requirements for school lunches and other public nutrition programs.

Five life lessons from your immune system

Five life lessons from your immune system

January 7, 2019 6.04am AEDT Are you exhausted? Your immune cells might be too. from www.shutterstock.com

Author

  1. Joanna Groom Laboratory Head, Walter and Eliza Hall Institute

Disclosure statement

Joanna Groom receives funding from the National Health and Medical Research Council, Australian Research Council and is a WEHI CSL Centenary Fellow.

This article is part of our occasional long read series Zoom Out, where authors explore key ideas in science and technology in the broader context of society and humanity.


Scientists love analogies. We use them continually to communicate our scientific approaches and discoveries.

As an immunologist, it strikes me that many of our recurring analogies for a healthy, functioning immune system promote excellent behaviour traits. In this regard, we should all aim to be a little more like the cells of our immune system and emulate these characteristics in our lives and workplaces.

Here are five life lessons from your immune system.


Read more: The bugs we carry and how our immune system fights them


1. Build diverse and collaborative teams

Our adaptive immune system works in a very specific way to detect and eradicate infections and cancer. To function, it relies on effective team work.

At the centre of this immune system team sits dendritic cells. These are the sentinels and leaders of the immune system – akin to coaches, CEOs and directors.

They have usually travelled widely and have a lot of “life experience”. For a dendritic cell, this means they have detected a pathogen in the organs of the body. Perhaps they’ve come into contact with influenza virus in the lung, or encountered dengue fever virus in the skin following a mosquito bite.

Dendritic cells form a surveillance network – shown here as reddish stained cells in skin. Ed Uthman (Houston, TX, USA) via Wikimedia Commons, CC BY

After such an experience, dendritic cells make their way to their local lymph nodes – organs structured to facilitate immune cell collaboration and teamwork.

Here, like the best leaders, dendritic cells share their life experiences and provide vision and direction for their team (multiple other cell types). This gets the immune cell team activated and working together towards a shared goal – the eradication of the pathogen in question.

The most important aspect of the dendritic cell strategy is knowing the strength of combined diverse expertise. It is essential that immune team members come from diverse backgrounds to get the best results.

To do this, dendritic cells secrete small molecules known as chemokines. Chemokines facilitate good conversations between different types of immune cells, helping dendritic cells discuss their plans with the team. In immunology, we call this “recruitment”.

This 3D image of a lymph node shows the cells that produce chemokines in red and blue. Joanna Groom/WEHI, Author provided

Much like our workplaces, diversity is key here. It’s fair to say, if dendritic cells only recruited more dendritic cells, our immune system would completely fail its job. Dendritic cells instead hire T cells (among others) and share the critical knowledge and strategy to steer effective action of immune cells.

T cells can then pass these plans down the line – either preparing themselves to act directly on the pathogen, or working alongside other cell types, such as B cells that make protective antibodies.

In this way, dendritic cells establish a rich and diverse team that works together to clear infections or cancer.

2. Learn through positive and negative feedback

Immune cells are excellent students.

During development, T cells mature in a way that depends on both positive and negative feedback. This occurs in the thymus, an organ found in the front of your chest and whose function was first discovered by Australian scientist Jacques Miller (awarded the 2018 Japan Prize for his discoveries).


Read more: Gus Nossal: It’s Australian Jacques Miller’s turn for a Nobel Prize


As they mature, T cells are exposed to a process of trial and error, and take on board criticism and advice in equal measure, to ensure they are “trained” to respond appropriately to what they “see” (for example, molecules from your own body, or from a foreign pathogen) when they leave the thymus.

Importantly, this process is balanced, and T cells must receive both positive and negative feedback to mature appropriately – too much of either on its own is not enough.

In the diverse team of the immune system, cells can be both the student and the teacher. This occurs during immune responses with intense cross-talk between dendritic cells, T cells and B cells.

In this supportive environment, multiple rounds of feedback allow B cells to gain a tighter grip on infections, tailoring antibodies specifically towards each pathogen.

The result of this feedback is so powerful, it can divert cells away from acting against your own body, instead converting them into active participants of the immune system team.

Developing avenues that promote constructive feedback offers potential to correct autoimmune disorders.

The colours in this magnified slice through a lymph node show different cell types interacting as part of an immune response. Joanna Groom/WEHI, Author provided

Read more: Curious Kids: Why does my snot turn green when I have a cold?


3. A unique response for each situation

Our immune system knows that context is important – it doesn’t rely on a “one-size–fits-all” approach to resolve all infections.

This allows the cells of our immune system to perfectly respond to different types of pathogens: such as viruses, fungi, bacteria and helminths (worms).

In these different scenarios, even though the team members contributing to the response are the same (or similar), our immune system displays emotional intelligence and utilises different tools and strategies depending on the different situations, or pathogens, it encounters.

Importantly, our immune system needs to carefully control attack responses to get rid of danger. Being too heavy handed leaves us with collateral tissue damage, such as is seen allergy and asthma. Conversely, weak responses lead to immunodeficiencies, chronic infection or cancer.

A major research aim for people working in immunology is to learn how to harness balanced and tailored immune responses for therapeutic benefit.


Read more: Can I prevent food allergies in my kids?


4. Focus on work/life balance

When we are overworked and poorly rested, we don’t function at our peak. The same is true for our immune cells.

An overworked immune cell is commonly referred to as being “chronically exhausted”. In this state, T cells are no longer effective at attacking tumour or virus-infected cells. They are lethargic and inefficient, much like us when we overdo it.

For T cells, this switch to exhaustion helps ensure a balanced response and avoids collateral damage. However, viruses and cancers exploit this weakness in immune responses by deliberately promoting exhaustion.

The rapidly advancing field of immunotherapy has tackled this limitation in our immune system head-on to create new cancer therapeutics. These therapies release cells of their exhaustion, refresh them, so they become effective once more.

This therapeutic avenue (called “immune checkpoint inhibition”) is like a self-care day spa for your T cells. It revives them, renewing their determination and efficiency.

This has revolutionised the way cancer is treated, leading to the award of the 2018 Nobel prize in Medicine to two of its pioneers, James P. Allison and Tasuku Honjo.


Read more: INTERACTIVE: We mapped cancer rates across Australia – search for your postcode here


5. Learn from life experiences

The cornerstone of our adaptive immune system is the ability to remember our past infections. In doing so, it can respond faster and in a more targeted manner when we encounter the same pathogen multiple times.

Quite literally, if it doesn’t kill you, it makes your immune system stronger.

Vaccines exploit this modus operandi, providing immune cells with the memories without the risk of infection.

Work still remains to identify the pathways that optimise formation of memory cells that drive this response. Researchers aim to discover which memories are the most efficient, and how to make them target particularly recalcitrant infections, such as malaria, HIV-AIDS and seasonal influenza.

While life might not have the shortcuts provided by vaccines, certainly taking time to reflect and learn after challenges can allow us to find better, faster solutions to future problems.


Read more: Explainer: how viruses can fool the immune system

Your poo is (mostly) alive. Here’s what’s in it

Your poo is (mostly) alive. Here’s what’s in it

Human poo is a concoction made up mostly of water with a sprinkling of the solid stuff. from www.shutterstock.com

If you’ve ever thought your poo is just a bunch of dead cells, think again. Most of it is alive, teeming with billions of microbes. Here’s what studies in healthy adults reveal makes up our poo.

Water

Our faeces is largely (75%) made up of water, although this differs from person to person.

Vegetarians have a higher water content in their stools. Those who consume less fibre and more protein have a lower water content. Fibre has a high water-carrying ability and makes our stools more bulky, increases the frequency of bowel movements and makes the process of passing bowel motions easier.


Read more: Health Check: what your pee and poo colour says about your health


The other 25% of faeces is made up of solids, which are mainly organic (relating to living matter) materials. A small proportion of solids is made up of inorganic material such as calcium and iron phosphate as well as dried constituents of digestive juices.

Around 25-54% of the organic material is made up of microbes (dead and living), such as bacteria and viruses.

Our poo is teeming with microbes, most of them alive. www.shutterstock.com

Microbes

Bacteria in faeces have been extensively studied. It’s estimated there are nearly 100 billion bacteria per gram of wet stool.

One study that looked at a collection of fresh stools in oxygen-free conditions (as oxygen can damage certain types of bacteria) found almost 50% of the bacteria were alive.

The different types of bacteria present in faeces can influence how hard or loose stool samples can be. For example, Prevotella bacteria, which can be found in the mouth, vagina and gut, are more commonly seen in those with soft stools. In fact, a high-fibre diet is strongly associated with these bacteria.

Ruminococcaceae bacteria, which are common gut microbes that break down complex carbohydrates, favour harder stools.

Viruses have been less studied than bacteria as components of the gut microbiota – the population of bacteria and viruses that live in our gut. It is estimated there are 100 million to 1 billion viruses per gram of wet faeces in most of us.

This number can change considerably when people become sick with viral gastroenteritis, such as in norovirus infections, where levels of more than a trillion viruses per gram of stool can be found.

What is the human microbiome?

Certain types of viruses that infect bacteria, called bacteriophages, have been linked to diseases of the gut like Crohn’s disease and ulcerative colitis.


Read more: So you think you have IBS, coeliac disease or Crohn’s? Here’s what it might mean for you


Archaea are bacteria-like microbes that can inhabit some of the most extreme environments on Earth such as hot springs, deep sea vents or extremely acidic waters. Archaea that produce methane are known to live in the human gut and account for around 10% of non-oxygen-dependent microbes.

Such methane-producing archaea like Methanobrevibacter are associated with harder stools and constipation as methane can slow down intestinal movement. It is believed there are around 100 million archaea per gram of wet faeces.

Single-celled fungi (yeasts) are present in the gut of about 70% of healthy adults. They occur in estimated concentrations of up to a million microorganisms per gram of wet faeces but comprise only a small proportion (0.03%) of all microbes.

Other organic material

Some of the organic material includes carbohydrates or any other undigested plant matter, protein and undigested fats. Faeces does not contain large quantities of carbohydrates as the majority of what we eat is absorbed. However, undigested amounts remain as dietary fibre.

Our faeces don’t contain a large proportion of carbohydrates as most are absorbed in the body. from shutterstock.com

Some 2-25% of organic matter in faeces is due to nitrogen-containing substances such as undigested dietary protein, and protein from bacteria and cells lining the colon that have been shed.

Fats contribute 2-15% of the organic material in our faeces. The amount of fat excreted into our stools is highly dependent on dietary intake. Even with no fat intake, though, we do get some excretion of fat into our faeces. Fat in faeces can come from bacteria in the form of short-chain fatty acids when they ferment foods, in addition to undigested dietary fat.

Plastic particles

A recent study has found that microscopic plastic particles can appear in our faeces when we drink from plastic bottles or eat foods that have been wrapped in plastic.

This small study of eight participants who were exposed to plastics in their food and drink identified up to nine different types of plastics in their stools. But we need larger studies and additional analytical research to understand the clinical significance of this.

Poo is different in disease

Not everyone’s poo is going to be the same. Diseases such as inflammatory bowel disease can lead to changes in the type of bacteria in our gut and result in raised inflammatory proteins that can be detected in our stool.

The presence of blood in the stool could signal bowel cancer, though this isn’t always the case. Fortunately there is a good screening test that can pick up the presence of trace blood in the stools and lead to further investigations such as a colonoscopy.

Menopausal hormone therapy and breast cancer: what is the evidence from randomized trials?

Climacteric. 2018 Oct 9:1-8. doi: 10.1080/13697137.2018.1514008. [Epub ahead of print]

Menopausal hormone therapy and breast cancer: what is the evidence from randomized trials?

Hodis HN1, Sarrel PM2,3.

Author information

Abstract

The relationship between menopausal hormone therapy (HT) and breast cancer is complex and further complicated by misinformation, perception, and overgeneralization of data. These issues are addressed in this mini-review through the lens of the Women’s Health Initiative (WHI) that has colored the view of HT and breast cancer. In the WHI, unopposed conjugated equine estrogen (CEE) reduced breast cancer risk and mortality. In the WHI CEE plus continuously combined medroxyprogesterone acetate (MPA) trial, although the hazard ratio (HR) was elevated it was statistically non-significant for an association between CEE + MPA and breast cancer. In fact, the increased HR was not due to an increased breast cancer incidence rate in women randomized to CEE + MPA therapy but rather due to a decreased and unexpectedly low breast cancer rate in the subgroup of women with prior HT use randomized to placebo. For women who were HT naïve when randomized to the WHI, the breast cancer incidence rate was not affected by CEE + MPA therapy relative to placebo for up to 11 years of follow-up. The current state of science indicates that HT may or may not cause breast cancer but the totality of data neither establish nor refute this possibility. Further, any association that may exist between HT and breast cancer appears to be rare and no greater than other medications commonly used in clinical medicine.

Here’s what to look out for in your 40s, 60s, 80s and beyond

December 26, 2018 6.31am AEDT You’re another year older but that doesn’t have to mean poorer health. Lorene Farrugia

Authors

  1. Stephanie Harrison Research fellow, South Australian Health & Medical Research Institute
  2. Azmeraw T. Amare Postdoc researcher, South Australian Health & Medical Research Institute
  3. Jyoti Khadka Research Fellow, South Australian Health & Medical Research Institute
  4. Maria Carolina Inacio Director, Registry of Older South Australians, South Australian Health & Medical Research Institute
  5. Sarah Bray Registry of Older South Australians (ROSA) – Project Manager & Consumer Engagement Officer, South Australian Health & Medical Research Institute
  6. Tiffany Gill Senior Research Fellow, University of Adelaide

Disclosure statement

Maria Carolina Inacio receives funding from NHMRC (APP1148106) and MRFF (APP1152268).

Azmeraw T. Amare, Jyoti Khadka, Sarah Bray, Stephanie Harrison, and Tiffany Gill do not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and have disclosed no relevant affiliations beyond their academic appointment.

Partners

University of Adelaide

University of Adelaide provides funding as a member of The Conversation AU.

View all partnersRepublish this article

Republish

Republish our articles for free, online or in print, under Creative Commons licence.

Many diseases develop and become more likely as we age. Here are some of the most common conditions, and how you can reduce your risk of getting them as you clock over into a new decade.

Maintaining a healthy weight can reduce the risk of developing arthritis, coronary heart disease, and other common and related conditions, including back pain, type 2 diabetes, stroke, and many cancers. But almost one-third of Australians in their 40s are obese and one in five already have arthritis.


Read more: Arthritis isn’t just a condition affecting older people, it likely starts much earlier


From the age of 45 (or 35 for Aboriginal and Torres Strait Islanders), heart health checks are recommended to assess risk factors and initiate a plan to improve the health of your heart. This may include changing your diet, reducing your alcohol intake, increasing your physical activity, and improving your well-being.

Checks to identify your risk of type 2 diabetes are also recommended every three years from age 40 (or from age 18 for Aboriginal and Torres Strait Islanders).

If you don’t already have symptoms of arthritis or if they’re mild, this decade is your chance to reduce your risk of the disease progressing. Focus on the manageable factors, like shedding excess weight, but also on improving muscle strength. This may also help to prevent or delay sarcopenia, which is the decline of skeletal muscle tissue with ageing, and back pain.

Achieving and maintaining a healthy weight will set you up for decades of better health. Sue Zeng

Most people will begin to experience age-related vision decline in their 40s, with difficulty seeing up close and trouble adjusting to lighting and glare. A baseline eye check is recommended at age 40.

In your 50s

In your 50s, major eye diseases become more common. Among Australians aged 55 and above, age-related macular degeneration, cataracts, diabetes-related eye diseases and glaucoma account for more than 80% of vision loss.

A series of health screenings are recommended when people turn 50. These preventive measures can help with the early detection of serious conditions and optimising your treatment choices and prognosis. Comprehensive eye assessments are recommended every one to two years to ensure warning signs are detected and vision can be saved.

National cancer screening programs for Australians aged 50 to 74, are available every two years for bowel and breast cancer.


Read more: Women should be told about their breast density when they have a mammogram


To screen for bowel cancer, older Australians are sent a test in the post they can do at home. If the test is positive, the person is then usually sent for a colonoscopy, a procedure in which a camera and light look for abnormalities of the bowel.

In 2016, 8% of people screened had a positive test result. Of those who underwent a colonoscopy, 1 in 26 were diagnosed with confirmed or suspected bowel cancer and one in nine were diagnosed with adenomas. These are potential precursors to bowel cancer which can be removed to reduce your future risk.

To check for breast cancer, women are encouraged to participate in the national mammogram screening program. More than half (59%) of all breast cancers detected through the program are small (less than or equal to 15mm) and are easier to treat (and have better survival rates) than more advanced cancers.

In your 60s

Coronary heart disease, chronic obstructive pulmonary disease (a disease of the lungs that makes breathing difficult), and lung cancer carry the biggest disease burden for people in their 60s.

If you’re a smoker, quitting is the best way to improve both your lung and heart health. Using evidence-based methods to quit with advice from a health professional or support service will greatly improve your chances of success.

Quitting smoking is the best way to improve your health. Ian Schneider

The build-up of plaques in artery walls by fats, cholesterol and other substances (atherosclerosis) can happen from a younger age. But the hardening of these plaques and narrowing of arteries, which greatly increases the risk of heart disease and stroke, is most likely to occur from age 65 and above.

Exercise protects against atherosclerosis and research consistently shows any physical activity is better than nothing when it comes to heart health. If you’re not currently active, gradually build up to the recommended 30 minutes of moderate-intensity exercise on most, preferably all, days.


Read more: Too much salt and sugar and not enough exercise – why Australians’ health is lagging


Other potentially modifiable risk factors for stroke include high blood pressure, a high-fat diet, alcohol consumption, and smoking.

Your 60s is also a common decade for surgeries, including joint replacements and cataract surgery. Joint replacements are typically very successful, but are not an appropriate solution for everyone and are not without risks. After a joint replacement, you’ll benefit from physiotherapy, exercise, and maintaining a healthy weight.

The treatment for cataracts is to surgically remove the cloudy lens. Cataract surgery is the most common elective surgery worldwide, with very low complication rates, and provides immediate restoration of lost vision.

In your 70s

Many of the conditions mentioned above are still common in this decade. It’s also a good time to consider your risk of falls. Four in ten people in their 70s will have a fall and it can lead to a cascade of fractures, hospitalisations, disability and injury.

Osteoporosis is one cause of falls. It occurs most commonly in post-menopausal women but almost one-quarter of people with osteoporosis are men. Osteoporosis is often known as a silent disease because there are usually no symptoms until a fracture occurs. Exercise and diet, including calcium and vitamin D, are important for bone health.

Exercise and diet can improve bone health. Geneva, Switzerland

Older people are also vulnerable to mental health conditions because of a combination of reduced cognitive function, limitations in physical health, social isolation, loneliness, reduced independence, frailty, reduced mobility, disability, and living conditions.

In your 80s and beyond

Dementia is the second most common chronic condition for Australians in their 80s, after coronary heart disease – and it’s the most common for people aged 95 and above.

Many people think dementia is a normal part of the ageing process, but around one-third of cases of dementia could be prevented by reducing risk factors such as high blood pressure and obesity at mid-life.


Read more: Why people with dementia don’t all behave the same


Early diagnosis is important to effectively plan and initiate appropriate treatment options which help people live well with dementia. But dementia remains underdiagnosed.

Around 70% of Australians aged 85 and above have five or more chronic diseases and take multiple medications to manage these conditions. Effective medication management is critical for people living with multiple conditions because medications for one condition may exacerbate the symptoms of a different coexisting condition.

Hysterectomy causes sleep problems in menopause

Menopause. 2018 Nov 12. doi: 10.1097/GME.0000000000001257. [Epub ahead of print]

Sleep disturbance in women who undergo surgical menopause compared with women who experience natural menopause.

Cho NY1, Kim S2, Nowakowski S3,4, Shin C2,5, Suh S1.

Author information

Abstract

OBJECTIVE:

Women who undergo surgical menopause (SM) experience a relatively more acute and precipitous drop of estrogen compared with women who experience natural menopause (NM). Few studies, however, have compared sleep quality in women who experience natural versus SM.

METHODS:

Participants were 526 postmenopausal women (mean age 60.2 ± 7.64). All participants completed self-report questionnaires about insomnia symptoms, sleep-interfering behaviors, depression, sleep quality, and gynecological history. Analysis of covariance was conducted to compare women who experienced NM versus SM on sleep variables. Logistic regression analysis was used to determine whether NM or SM groups predicted insomnia status. Regression-based moderation analysis was conducted to explore the moderating effect of type of menopause on the relationship between sleep-interfering behaviors and insomnia symptoms.

RESULTS:

Among the sample, 81.6% (n = 429) reported going through NM and 18.4% (n = 97) reported going through SM. The SM group was significantly younger by 7.2 years (P < 0.001). Women in the SM group reported significantly worse sleep quality (P = 0.007), especially for sleep duration (P = 0.001) and habitual sleep efficiency (P = 0.010) compared with women in the NM group. Regression analysis indicated that individuals in the SM group were 2.131 (95% CI 1.055-4.303) times more likely to have insomnia compared with the NM group (P = 0.027). In addition, women in the SM group who displayed more sleep-interfering behaviors also had a higher severity of insomnia symptoms compared with women who experience NM (ß = 0.26, P = 0.03).

CONCLUSIONS:

Menopause can be both physically and psychologically challenging, but women who undergo SM experience worse sleep quality compared with women who experience NM, and may benefit from behavioral interventions.

Hormone therapy and breast cancer

Climacteric. 2018 Dec 17:1-4. doi: 10.1080/13697137.2018.1527305. [Epub ahead of print]

Hormone therapy and breast cancer: risk communication and the ‘perfect storm’.

Reid RL1.

Author information

Abstract

Many factors are considered when a woman estimates her personal risk of breast cancer. Common to most decisions are four separate influences that have convinced the public and many health-care providers that breast cancer is the greatest concern for menopausal women and that menopausal hormone therapy (MHT) is generally responsible.

Historically there have been well-documented situations in which big pharma and doctors have not put patient interests first.(Surptise, surprise – my comment.)

Conflicting reports about the safety of MHT and the media imperative to always increase readership by presenting a compelling scary story have created an underlying distrust of science, doctors, and MHT. Numerical and statistical illiteracy in the general population creates a situation where lotteries succeed despite astronomical odds and the risks of medical interventions are exaggerated by their description using relative, rather than absolute, risks.

Finally, mammographic overdiagnosis contributing to improved breast cancer survival has contributed to the ‘popularity paradox’ (more screening – more enthusiasm) especially among survivors and advocacy groups. As a result, worry about breast cancer has overshadowed concern about cardiovascular diseases as the major cause of death and disability in the later years. The ongoing challenge for clinicians dealing with menopausal women is to bridge the gap in risk perception with evidence-based common-sense advice.

Should you take probiotics when you’re on antibiotics?

Health Check: should you take probiotics when you’re on antibiotics?

We still don’t know what types of bacteria are truly beneficial. Andry Jeymsss/Shutterstock

If you take antibiotics, there’s a good chance you’ll also get diarrhoea.

Antibiotics kill harmful bacteria that cause disease. But they also cause collateral damage to the microbiome, the complex community of bacteria that live in our gut. This results in a profound, though usually temporary, depletion of the beneficial bacteria.

One popular strategy to mitigate the disruption is to take a probiotic supplement containing live bacteria during, or following, a course of antibiotics.


Read more: Healthy guts are swarming with bugs, so what do they do?


The logic is simple: beneficial bacterial in the gut are damaged by antibiotics. So why not replace them with the “beneficial” bacterial strains in probiotics to assist gut bacteria returning to a “balanced” state?

But the answer is more complicated.

There is currently some evidence that taking probiotics can prevent antibiotic-associated diarrhoea. This effect is relatively small, with 13 people needing to take probiotics for one episode of diarrhoea to be averted.

But these studies have often neglected to evaluate potential harms of probiotic use and haven’t looked at their impact on the wider gut microbiome.

Pros and cons of probiotics

The assumption that there is little downside to taking probiotics was challenged in a recent Israeli study.

The participants were given antibiotics and split into two groups: the first group was given an 11-strain probiotic preparation for four weeks; the second was given a placebo, or dummy pill.

The researchers found the antibiotic damage to the gut bacteria of those in the first group allowed the probiotic strains to effectively colonise the gut. But this colonisation delayed the normal recovery of the microbiota, which remained perturbed for the entire six month study period.

In contrast, the microbiota of the second group returned to normal within three weeks of finishing antibiotics.


Read more: Health Check: should healthy people take probiotic supplements?


This research exposes a perhaps unexpected truth: we still don’t know what types of bacteria are truly beneficial or even what constitutes a healthy microbiome.

The answer is unlikely to be that individual bacterial strains are particularly helpful.

It’s more likely a diverse community of thousands of different types of microbes working together can provide health benefits. This microbial community is as individual as each one of us, meaning there is not just one configuration that will result in health or illness.

So, it’s unlikely that the addition of one or even 11 strains of bacteria in a probiotic could somehow balance this complex system.

A more effective (but less palatable) alternative?

The Israeli study also explored an alternative approach to microbiome restoration.

One group of participants had their own stool collected and frozen prior to antibiotic treatment. It was then re-instilled into their gut at the end of the antibiotic therapy.

This treatment, known as autologous faecal transplantation, was able to restore the microbiome to original levels after just eight days. The other group took 21 days to recover.


Read more: Poo transplants and probiotics – does anything work to improve the health of our gut?


This approach has also been shown to effectively restore the gut microbiome following combined antibiotic and chemotherapy treatment. These patients are predictably at risk of serious complications, such as bloodstream infection, as a result of microbiome disruption.

Research currently underway will help us understand whether microbiome restoration with autologous faecal transplantation will translate into tangible benefits for these patients.

But such an approach would not be a realistic option for most people.

Feed the good bacteria

Good food for gut bacteria. Roosa Kulju

A more practical strategy to aid recovery is to provide the good bacteria in your gut with their preferred source of nutrition: fibre. Fibrous compounds pass undigested through the small intestine and into the colon, where they act as fuel for bacterial fermentation.

So if you’re taking antibiotics or have recently finished a course, make sure you eat plenty of vegetables, fruit and wholegrains. Your gut bacteria will thank you for it.

Knee osteoarthritis and menopausal hormone therapy

One of the many benefits of taking oestrogen in the menopause, is its very positive benefit to all the joints, especially knees.

Menopause. 2018 Dec 21. doi: 10.1097/GME.0000000000001280. [Epub ahead of print]

Knee osteoarthritis and menopausal hormone therapy in postmenopausal women: a nationwide cross-sectional study.

Jung JH1,2, Bang CH3, Song GG1,2, Kim C4, Kim JH1,2, Choi SJ1,5.

Author information

Abstract

OBJECTIVE:

The incidence of osteoarthritis (OA) increases after menopause, and may be related to hormonal changes in women. Estrogen deficiency is known to affect the development of OA, and menopausal hormone therapy (MHT) is suggested to be related to the development of OA. However, the relationship between knee OA and MHT remains controversial. The association between knee OA prevalence and MHT was investigated using large-scale national data.

METHODS:

Data were collected from 4,766 postmenopausal women from the Korea National Health and Nutrition Examination Survey (2009-2012). MHT was defined as regular hormone medication for ≥1 year, and demographic and lifestyle variables were compared between the MHT and non-MHT groups. Knee OA was defined according to symptoms and radiographic findings.

RESULTS:

In the multiple logistic regression models, the OA odds ratio was 0.70 for the MHT group (95% confidence interval 0.50-0.99), compared with the non-MHT group.

CONCLUSIONS:

The prevalence of knee OA was lower in participants with MHT than in those without MHT.